Richard Saperstein - Concepedia

Author

Richard Saperstein

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

RICHARD SAPERSTEIN, Richard Saperstein

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy

About

Richard Saperstein is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	24	2.5K
2	Natural Sciences	9	9	1.2K
3	Health Sciences	6	6	729
4	Engineering	1	1	213
5	Public Health	1	1	32

Richard Saperstein

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
A potent cyclic hexapeptide analogue of somatostatin Daniel F. Veber, Roger Freidinger, Debra S. Perlow, Nature Medicinal ChemistryBiochemistryMedicineNatural SciencesMechanism Of Action	1981	413
Bioactive Conformation of Luteinizing Hormone-Releasing Hormone: Evidence from a Conformationally Constrained Analog Roger Freidinger, Daniel F. Veber, Debra S. Perlow, Science Bioorganic ChemistryMolecular BiologyChemical BiologyPharmaceutical ChemistryBioactive Conformation	1980	313
Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting J Berger, Chhabi Biswas, Pasquale P. Vicario, Nature Metabolic SyndromeDiabetes ManagementInsulin-responsive Glucose TransporterMedicineInsulin Management	1989	300
Highly active cyclic and bicyclic somatostatin analogues of reduced ring size Daniel F. Veber, Frederick W. Holly, Ruth F. Nutt, Nature Medicinal ChemistryEngineeringHeterocyclicReduced Ring SizeDrug Discovery	1979	213
The Isolation and Metabolism of Brown Fat Cells John N. Fain, Nora Reed, Richard Saperstein Journal of Biological Chemistry Lipid AnalysisBrown Fat CellsCellular PhysiologyMetabolic SyndromeFatty Acids	1967	173
A super active cyclic hexapeptide analog of somatostatin Daniel F. Veber, Richard Saperstein, Ruth F. Nutt, Life Sciences Molecular PharmacologyMedicinal ChemistryMedicineNatural SciencesPeptide Synthesis	1984	165
A Novel Glucagon Receptor Antagonist Inhibits Glucagon-Mediated Biological Effects Sajjad A. Qureshi, Mari R. Candelore, Dan Xie, Diabetes Molecular PhysiologyGlycosylationBiochemistryFunctional SelectivityMedicine	2004	109
Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells Richard Saperstein, Pasquale P. Vicario, H.V. Strout, Biochemistry Intact CellsInsulin ReceptorGlucose UptakeInsulin SignalingMetabolic Syndrome	1989	108
Vanadate Treatment of Streptozotocin Diabetic Rats Restores Expression of the Insulin-Responsive Glucose Transporter in Skeletal Muscle H.V. Strout, Pasquale P. Vicario, Chhabi Biswas, Endocrinology Metabolic SyndromeSkeletal MuscleInsulin-responsive Glucose TransporterMedicineVanadate Treatment	1990	78
Nonreducible cyclic analogues of somatostatin Daniel F. Veber, R. G. Strachan, Susan J. Bergstrand, Journal of the American Chemical Society Medicinal ChemistryMolecular SciencesBioorganic ChemistryNonreducible Cyclic AnaloguesHeterocyclic	1976	73

Page 1